Stockholders' Equity

9 Months Ended

Mar. 31, 2024

Equity [Abstract]

Stockholders' Equity

STOCKHOLDERS’ EQUITY

AOCI

The following table presents changes by component for the three months ended March 31, 2024 and 2023:

($000s)	Foreign Currency Translation Adjustment		Derivative Valuation		Defined Benefit Plan		Total
Balance as of December 31, 2022	$	(5,149)	$	(86)	$	103	$	(5,132)
Foreign currency translation	(1,039)		—		—		(1,039)
Unrealized gain on cash flow hedges	—		188		—		188
Reclassifications to earnings	—		28		—		28
Balance as of March 31, 2023	$	(6,188)	$	130	$	103	$	(5,955)

($000s)	Foreign Currency Translation Adjustment		Derivative Valuation		Defined Benefit Plan		Total
Balance as of December 31, 2023	$	(6,282)	$	77	$	72	$	(6,133)
Foreign currency translation	(288)		—		—		(288)
Unrealized loss on cash flow hedges	—		(165)		—		(165)
Reclassifications to earnings	—		34		—		34
Balance as of March 31, 2024	$	(6,570)	$	(54)	$	72	$	(6,552)

The following table presents changes by component for the nine months ended March 31, 2024 and 2023:

($000s)	Foreign Currency Translation Adjustment		Derivative Valuation		Defined Benefit Plan		Total
Balance as of June 30, 2022	$	(4,026)	$	(639)	$	103	$	(4,562)
Foreign currency translation	(2,162)		—		—		(2,162)
Unrealized loss on cash flow hedges	—		(299)		—		(299)
Reclassifications to earnings	—		1,068		—		1,068
Balance as of March 31, 2023	$	(6,188)	$	130	$	103	$	(5,955)

($000s)	Foreign Currency Translation Adjustment		Derivative Valuation		Defined Benefit Plan		Total
Balance as of June 30, 2023	$	(6,260)	$	(124)	$	72	$	(6,312)
Foreign currency translation	(310)		—		—		(310)
Unrealized loss on cash flow hedges	—		(35)		—		(35)
Reclassifications to earnings	—		105		—		105
Balance as of March 31, 2024	$	(6,570)	$	(54)	$	72	$	(6,552)

Share buyback

On September 18, 2023, the Company announced that the board of directors (the "Board") had authorized a share repurchase program under which the Company may repurchase up to $30 million of its shares over the next six months beginning September 18, 2023 (the “Share Repurchase Program”). During the three and nine months ended March 31, 2024, we repurchased 501,549 and 1,124,876 shares of our common shares under the Share Repurchase Program for $8.1 million and $18.6 million, respectively, which the Company funded with available cash. The Share Repurchase Program expired on March 18, 2024.

During the nine months ended March 31, 2023, we repurchased 17,558 shares of our common shares under our previous share repurchase program for $0.3 million. The previous share repurchase program was announced in December 2021 and expired a year later.